The abstract is read at the publisher; the summary is JClub's.
In a cohort of 34 AD dementia patients, gut microbiome–personalized whole-body models predict increased blood production capacities for S-adenosyl-L-methionine, L-arginine, creatine, taurine, and formate.
- Why it matters: Prior microbiome-personalized modeling work in healthy aging predicted AD-linked metabolic effects, but those predictions were not validated in actual AD dementia or MCI patients.
- What they did: The study built gut microbiome–personalized metabolic models for 34 AD dementia, 51 MCI, and 298 healthy controls, then used modeling-informed sensitivity plus LASSO-based taxonomic stability selection and elastic net regression to link predicted metabolite shifts to taxa.
- The result: Increased relative abundances of Bacteroides uniformis and Bacteroides thetaiotamicron were major drivers of the predicted metabolic changes in AD, and predictions were associated with APOE allelic variation in healthy individuals.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.